Rocket Pharmaceuticals, Inc. (FRA:9IP1)
2.762
+0.008 (0.29%)
At close: Jan 2, 2026
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of €347.03 million as of January 9, 2026. Its market cap has decreased by -69.75% in one year.
Market Cap
347.03M
Enterprise Value
177.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.76
Market Cap Chart
Since January 5, 2018, Rocket Pharmaceuticals's market cap has increased from 343.87M to 347.03M, an increase of 0.92%. That is a compound annual growth rate of 0.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 347.03M | 7.27% |
| Dec 31, 2025 | 323.53M | -74.47% |
| Dec 31, 2024 | 1.27B | -48.17% |
| Dec 29, 2023 | 2.44B | 76.39% |
| Dec 30, 2022 | 1.39B | 12.04% |
| Dec 31, 2021 | 1.24B | -54.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |